Articles tagged with Myopia
A University of Houston optometry researcher warns of the dangers of red-light laser myopia therapy for children, citing vision damage reports and the need for rigorous safety validation. The professor's quality improvement study found that two popular devices exceeded national standards for safety classifications.
A new study proposes that myopia is driven by how we use our eyes indoors, with prolonged close-up focus in low-light environments limiting retinal illumination. This mechanism could lead to a paradigm shift in understanding and controlling myopia progression and control.
A WVU research team is working to restore vision in people with inherited blindness due to genetic mutations in the Prominin1 gene. The team has observed encouraging early results using a mouse model and plans to investigate the therapy's effectiveness beyond initial restoration.
Researchers are testing whether low-concentrate atropine drops can delay the onset of myopia in children. The study aims to reduce the risk of sight-threatening complications later in life by decreasing how nearsighted someone becomes.
Researchers are conducting a national study to test the effectiveness of daily atropine drops in delaying and reducing nearsightedness in young children. The study aims to enroll over 600 children aged 6-11 who will receive either atropine or a placebo, with results comparing the timing of onset and progression of myopia.
A new study shows that laser treatment, PRK, is as safe and effective in treating myopia in older teenagers (17-18 years) as it is in adults. The procedure achieved excellent results with around 64% of teenagers' eyes achieving 20/20 vision.
Patients who had cataract surgery or received a new type of lens for presbyopia correction have excellent vision over near, intermediate, and far distances without glasses. The study found that nearly all patients needed glasses 'none' or 'a little of the time' for distance and intermediate vision.
Researchers developed a new treatment using specially formulated eye drops that improved near vision for patients with presbyopia. The study found that the majority of patients could read extra lines on the Jaeger chart after using the eye drops, and improvements were sustained for up to two years.
A study found that more than half of the general population in the USA and Europe experience dry eyes, with only 20% of European patients and 17% of US patients receiving a diagnosis. The delay in seeking treatment is concerning, as early intervention can prevent inflammation and worsening symptoms.
A diet rich in omega-3 fatty acids is associated with a lower risk of myopia in children, according to the Hong Kong Children Eye Study. Higher intake of omega-3 fatty acids was linked to shorter axial length and less refractive error.
Researchers highlight the potential of AI in diagnosing and treating myopia, detecting risk factors and predicting outcomes. However, challenges such as data quality and patient privacy must be addressed to improve widespread clinical application.
A landmark study shows that aspherical lenslets can effectively slow myopia progression in children, reducing the risk of high myopia by fourfold. The five-year clinical trial found HAL lenses reduced myopia progression by 58% and axial elongation by 52%, with no reported adverse effects.
A novel contact lens management system for children has won the top prize of $50,000 at the Duke-NUS Health Innovator Programme challenge. The project addresses hygiene, usability and discomfort challenges faced by children and adults alike.
A systematic review and dose-response meta-analysis found a daily 1-hour increment in digital screen time was associated with a 21% higher odds of myopia. Researchers suggest that exposure to screens for less than 1 hour per day may be safe, but prolonged use increases the risk of nearsightedness.
A University of Houston study found that wearing multifocal contact lenses for myopia control has a lasting effect, slowing eye growth and progression. The study, which followed children from ages 7 to 11 for three years, showed that the treatment benefit remained even after discontinuing treatment.
A new study found that young nearsighted kids who wear bifocal contact lenses do not lose the benefits of treatment once they stop wearing them, with myopia progression continuing at age-expected rates. The study suggests a lower cost and more options for patients with healthier eyes.
CEOs innovate based on stock recommendations and analyst feedback, which can foster explorative activities like R&D. However, many sacrifice long-term sustainability for immediate returns, incentivized by their compensation packages.
Researchers at Arizona State University have developed new diagnostic tools using artificial intelligence (AI) to help identify myopic maculopathy, a serious eye condition. The AI-powered systems can analyze retinal images and predict the correct classification of the disease, enabling more accurate treatment recommendations.
The global prevalence of myopia is projected to exceed 740 million cases by 2050, with females, East Asians, and those in urban areas showing higher rates. The condition's impact on children and teens is expected to be significant, with low and middle-income countries predicted to have a higher prevalence than high-income countries.
A 1-year study found that continuous outdoor exposure with high sunlight intensity was associated with less myopic shift in children. Effective outdoor exposure patterns should be prioritized to prevent myopia in children.
Researchers at the University of East Anglia have developed a novel resin for 3D printing intraocular devices, offering unprecedented levels of customization and design precision. This innovation has potential to enhance eye care globally with tailored lenses, faster production, and cost reduction.
A team of researchers from Tokyo Medical and Dental University developed a novel kind of optical coherence tomography (OCT) to investigate the detailed structure of the sclera in living patients. They found that the sclera is divided into inner and outer layers with different structural arrangements, which can provide important insight...
A University of Houston optometry researcher has warned against using low-level red light therapy for myopia in children due to potential retinal damage. The therapy, which involves prolonged exposure to a red light-emitting instrument, can put the retina at risk of photochemical and thermal damage.
A study from China found a high prevalence of high and pathological myopia, yet inadequate patient education. The research highlights the need to improve awareness about these eye diseases to reduce adverse outcomes.
Researchers developed a machine-learning model to predict the risk of visual impairment in people with severe shortsightedness. The study used a dataset of 967 Japanese patients and found that the logistic regression-based model performed well at predicting visual impairment at 5 years.
Researchers using acoustic imaging measure eye size and growth to better understand myopia's contributing factors. Education level, light stimulation, and outdoor time are found to correlate with the development of myopia. Current solutions like glasses and contacts are being replaced by eyedrops for children and collaborative efforts ...
Scientists developed computational eye models to help patients and surgeons select ideal intraocular lenses and predict visual outcomes. The technology uses anatomical information of the patient's eye to provide guidance on expected optical quality post-operatively.
Researchers have developed high-resolution near-eye displays with integrated light field technology, overcoming limitations of earlier displays. The new designs feature improved resolution, pixel density, and vision correction capabilities, resulting in enhanced visual comfort and immersive VR experiences.
A nationwide study found that low-dose atropine eyedrops had no effect on slowing the progression of nearsightedness in children. The study contradicts earlier findings from East Asia and highlights racial differences in treatment response.
The grant investigates the unknown relationship between myopia and glaucoma by analyzing their effects on the ganglion cell complex. The research aims to identify early markers of glaucoma in myopic eyes, potentially reducing vision loss and improving quality of life.
A randomized controlled trial funded by NIH found low-dose atropine eyedrops to be no better than placebo in slowing myopia progression among US children. The study contradicts previous East Asian trials that showed a benefit from 0.01% atropine. Further research is needed to identify an optimal approach for preventing high myopia.
A randomized clinical trial found that low-dose atropine eye drops did not slow myopia progression or axial elongation in US school-age children. The results suggest that atropine, 0.01%, eye drops are not effective for controlling myopia in this population.
A randomized clinical trial suggests that low-dose atropine may provide a treatment option for childhood myopia progression. The study observed a significant reduction in myopia progression over 3 years.
A new clinical trial found that low-dose atropine eye drops are effective in slowing the progression of nearsightedness in children. The treatment showed significant improvements in limiting eyeglass prescription changes and inhibiting elongation of the eye, with a daily drop in each eye being enough to make a difference.
Researchers have developed a new instrument to thoroughly characterize the optical properties of specialized eyeglass lenses used to slow myopia progression. The study's findings provide valuable information on how these lenses interact with eye elongation and shed light on their effectiveness in real-world scenarios.
Researchers at SUNY Optometry aim to provide a deeper understanding of the biology of myopia, a leading cause of vision impairment worldwide. The study will investigate cellular and molecular mechanisms controlling eye growth and develop new treatments for refractive errors.
Researchers identified five genetic variants that progressively increase the risk of becoming nearsighted with more schooling, especially for university-level education. These findings provide new insights into biological pathways causing nearsightedness and its interaction with lifestyle factors.
A new study reveals less than half of people over 50 worldwide have received spectacles or contact lenses needed to correct refractive error. The World Health Organisation aims to increase treatment coverage by 40 percentage points by 2030.
Observational research suggests that 7-MX inhibits excessive eye lengthening and slows myopia progression in Danish children. The study found that higher doses of 7-MX were more effective in slowing myopia growth.
A new peer-reviewed study confirms MiSight 1 day contact lenses slow eye growth and halt myopia progression in 90% of children, with no loss of effectiveness over time. The longest-running soft contact lens study among children demonstrates sustained efficacy for nearly all children, regardless of age or initial refractive error.
A new study of UK Biobank adults found significantly increased rates of nearsightedness, particularly in children. The study suggests changing environmental factors and gene-environment interactions may be to blame for the rising trend.
A seven-year study by CooperVision indicates that MiSight 1 day contact lenses slow myopia progression without a rebound effect, even after treatment cessation. The lenses demonstrate sustained slowing of myopia progression across different ages and with varying levels of myopia.
A new study published in The Lancet Digital Health found a link between screen time and myopia in children and young adults. High levels of smart device exposure increased the risk of short-sightedness by up to 80%, according to researchers at Anglia Ruskin University.
Research investigated changes in myopia development among Chinese schoolchildren during digital learning and limited outdoor activities. The study found that the COVID-19 outbreak led to a significant increase in myopia prevalence among schoolchildren in China.
A Hong Kong study suggests a link between the COVID-19 pandemic and an increase in childhood short-sightedness, with children spending less time outdoors and more time on screens. The study found that around 1 in 5 children developed short-sightedness during the pandemic, compared to around 1 in 3 over three years.
CooperVision presented over 20 papers and posters on presbyopia, soft toric lens fitting, and myopia control. The research highlights the importance of patient input, toric lens performance attributes, and children's acceptance of myopia control interventions.
A new study compares axial elongation among children with untreated myopia progression, treated myopes, and emmetropes, revealing that normal eye growth continues as the child ages. The analysis suggests that myopic axial elongation may be superimposed on underlying physiological axial elongation.
People with myopia experience poorer sleep quality due to delayed circadian rhythms and lower melatonin production. The study highlights the importance of adequate sleep for good vision, particularly in children exposed to excessive screen time.
A six-year study found minimal impact on physiological response in children wearing daily disposable soft contact lenses, affirming their safety for correcting myopia and slowing its progression. The research also highlights the importance of lens fit, material, and patient habits in ensuring successful wear.
Researchers investigated the association between COVID-19 home confinement and myopia development in Chinese school-age children. The study found a significant increase in the progression of myopia after COVID-19 home confinement, highlighting the potential impact of prolonged screen time on eye health.
A large retrospective review of over 1,000 children found very low complication rates for soft contact lens wear, similar to those in adults. The study's findings offer reassurance to eye care professionals and parents about the safety of myopia management options.
The CooperVision MiSight 1 day clinical study found that nearly one in four children's eyes remain stable for myopia after six years. The study also suggests that commencing treatment at an older age can slow the rate of myopia progression.
Research shows that multifocal contact lenses can slow nearsightedness progression in children as young as 7 years old. A three-year clinical trial found that kids wearing bifocal contact lenses with a high reading power had slower eye growth, but no vision problems.
A clinical trial funded by the National Eye Institute found that multifocal contact lenses reduce worsening nearsightedness and slow eye growth in children. The study, published in the Journal of the American Medical Association, shows promising results for a new option in myopia control.
A new literature analysis published in Ophthalmic & Physiological Optics provides a comprehensive review of evidence-based information for managing myopia. The paper discusses various safety and efficacy considerations for behavioral, optical, and pharmaceutical pathways, as well as potential future avenues for myopia management.
A new study identified over 1,000 genetic variations in 450 genes linked to moderate to severe myopia. The research suggests that genetics can play a significant role in myopia, with specific genes involved in circadian rhythm and eye pigmentation.
The study aims to evaluate the safety and effectiveness of MicroPine, an atropine eye solution, in slowing myopic progression in children aged 3-12 years. Participants will receive MicroPine or a placebo for three years, with some receiving it for four years, and comprehensive eye care, glasses, and travel expenses covered.
Researchers at Flinders University have developed a new method to measure myopia, using OCT to identify irregularities in the eye's shape. This approach could lead to more effective monitoring and prevention of vision loss, as high myopia is expected to become the leading cause of blindness worldwide by 2050.
The FDA has approved MiSight 1 day, a daily wear contact lens that slows the progression of myopia in children aged 8-12. The lens is the first and only FDA-approved product clinically proven to slow myopia progression.
A new study suggests combining eye drops and contact lenses can effectively slow nearsightedness in children, with benefits seen in both high and low myopia cases. The combination treatment was found to be 28-38% more effective than using either method alone.